Retrieve available abstracts of 7 articles: HTML format
Single Articles
May 2025
ROTH H, Aronsohn A Innovative strategies to enhance access to HCV therapy.
Lancet. 2025 May 7:S0140-6736(25)00636-1. doi: 10.1016/S0140-6736(25)00636. PubMed
COOKE GS, Hung LM, Flower B, McCabe L, et al Treatment options to support the elimination of hepatitis C: an open-label,
factorial, randomised controlled non-inferiority trial.
Lancet. 2025 May 7:S0140-6736(25)00097-2. doi: 10.1016/S0140-6736(25)00097. PubMedAbstract available
August 2024
SALEEM SM, Haq Z Bridging gaps in vertical transmission of HIV, syphilis, and hepatitis B in
India.
Lancet. 2024;404:428-429. PubMed
April 2024
TORRES HA, Mustafayev K, Nastoupil LJ, Shelburne SA, et al Severe reactivation of seronegative occult hepatitis B after chemotherapy for
lymphoma.
Lancet. 2024;403:1372-1373. PubMed
March 2024
COUSINS S Egypt's hepatitis success story.
Lancet. 2024;403:1011-1012. PubMed
February 2024
HUANG S, Zhang X, Su Y, Zhuang C, et al Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year
results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2024 Feb 19:S0140-6736(23)02234-1. doi: 10.1016/S0140-6736(23)02234. PubMedAbstract available
September 2023
MARTINELLO M, Solomon SS, Terrault NA, Dore GJ, et al Hepatitis C.
Lancet. 2023;402:1085-1096. PubMedAbstract available